Association Between Perfluoroalkyl Substance (PFAS) Exposure and Nonalcoholic Fatty Liver Disease in Korean Adults: Results From the KoNEHS 2018–2020: A Cross‐Sectional Study
American Journal of Industrial Medicine · 2025
DOI: 10.1002/ajim.23732 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Industrial Medicine, 2025. Verfasst von Jisuk Yun und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Occupational and Environmental Medicine, Soonchunhyang University Cheonan Hospital, Cheonan, Korea. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease, Fluorocarbons, Environmental Exposure, Environmental Pollutants. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This work was supported by the Soonchunhyang University Research Fund., Soonchunhyang University.
Abstract (Originalsprache)
Objectives
Nonalcoholic fatty liver disease (NAFLD) is a major public health problem and the most common chronic liver disease today. In Korea, the prevalence and incidence of NAFLD are currently very high, causing a serious social burden. Perfluoroalkyl substances (PFAS) have been consistently implicated as a potential cause of NAFLD, but research in Koreans is limited.
Methods
Using data from the 4th Korean National Environmental Health Survey (KoNEHS, n = 2792), we investigated the association between PFAS blood levels and NAFLD. Multivariable logistic regression models were used to calculate odds ratios (ORs) for the effects of PFAS. A mediation analysis was also conducted to examine the mediating effect of obesity. Finally, weighted quantile sum (WQS) and G‐computation methods were implemented to evaluate the joint effect of PFAS mixtures. Hepatic steatosis index was used as a diagnostic tool for NAFLD. [Correction added on 15 May 2025, after first online publication: The KoNEHS n value was changed from 2859 to 2792 in this version.]
Results
Through multivariable logistic regression, statistically significant associations with NAFLD were observed for perfluorooctanoic acid (PFOA) (OR 1.09–1.39), perfluorooctansulfonate (PFOS) (1.09–1.40), perfluorohexanesulfonic acid (PFHxS) (1.04–1.22), perfluorononanoic acid (PFNA) (1.12–1.42), and total PFAS (1.21–1.81). We also found that obesity was a significant mediator for PFOA, PFNA, and total PFAS. The ORs for NAFLD obtained by WQS and G‐computation methods in the multivariable adjusted model were 1.10–1.46 and 1.08–1.32, respectively.
Conclusions
This study confirmed a significant association between some PFAS and increased odds of NAFLD. Excessive exposure to PFAS might explain the high prevalence and incidence of chronic liver disease in Koreans. Long‐term cohort studies are needed to assess geographic and occupational exposures in the Korean population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Occupational and Environmental Medicine, Soonchunhyang University Cheonan Hospital, Cheonan, Korea.
- Department of Statistics and Data Science, Korea National Open University, Korea.
ORCID-Profile: Jisuk Yun, Young-Sun Min
Förderung
- This work was supported by the Soonchunhyang University Research Fund.
- Soonchunhyang University
Zitieren
APA
Yun, J., & Min, Y. S. (2025). Association Between Perfluoroalkyl Substance (PFAS) Exposure and Nonalcoholic Fatty Liver Disease in Korean Adults: Results From the KoNEHS 2018–2020: A Cross‐Sectional Study. American Journal of Industrial Medicine. https://doi.org/10.1002/ajim.23732
Vancouver
Yun J, Min YS. Association Between Perfluoroalkyl Substance (PFAS) Exposure and Nonalcoholic Fatty Liver Disease in Korean Adults: Results From the KoNEHS 2018–2020: A Cross‐Sectional Study. American Journal of Industrial Medicine. 2025. doi:10.1002/ajim.23732
BibTeX
@article{Yun2025,
author = {Yun, Jisuk and Min, Young-Sun},
title = {Association Between Perfluoroalkyl Substance (PFAS) Exposure and Nonalcoholic Fatty Liver Disease in Korean Adults: Results From the KoNEHS 2018–2020: A Cross‐Sectional Study},
journal = {American Journal of Industrial Medicine},
year = {2025},
doi = {10.1002/ajim.23732}
}
EUVIMED